Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience.


Journal

Current research in translational medicine
ISSN: 2452-3186
Titre abrégé: Curr Res Transl Med
Pays: France
ID NLM: 101681234

Informations de publication

Date de publication:
02 2019
Historique:
received: 04 06 2018
revised: 06 08 2018
accepted: 07 08 2018
pubmed: 13 9 2018
medline: 1 4 2020
entrez: 13 9 2018
Statut: ppublish

Résumé

Gastrointestinal (GI) graft versus host disease (GVHD) occurs in up to 40% of patients undergoing allogenic hematopoietic stem cell transplantation (HSCT). However, the optimal endoscopic approach is still unclear and the area of the GI tract with the highest diagnostic yield is still a topic of debate. We compared the diagnostic yield of different anatomic site biopsies in the diagnosis of GI GVHD and assessed the correlation of endoscopic findings with histopathology. All cases of biopsy proven GI GVHD were obtained from pathology database AUBMC between 1/1/2005 and 31/8/2017. We retrospectively analyzed the demographical, clinical and endoscopic data. Nineteen patients were diagnosed with GI GVHD over 17.6 years. The most common presenting symptom was severe diarrhea (18 patients, 94.7%). Combining upper endoscopy and sigmoidoscopy with biopsies had the highest diagnostic yield of 90% in diagnosing GI GVHD compared to 63.6%, 78.6% and 77.8% for upper endoscopy, sigmoidoscopy and colonoscopy respectively. In macroscopically normal mucosa, the recto-sigmoid and duodenal biopsies had the highest diagnostic yield (75%). As for the macroscopically abnormal mucosa, the highest yield was for the recto-sigmoid biopsies (100%) in lower endoscopy and duodenal biopsies in the upper endoscopy (60%). In a patient suspected to have GI GVHD, the best endoscopic approach is the combination of upper endoscopy and flexible sigmoidoscopy with biopsies of normal as well as abnormal mucosa. It should be emphasized that normal mucosa be biopsied especially in the duodenum and recto-sigmoid for a better diagnostic yield.

Sections du résumé

BACKGROUND
Gastrointestinal (GI) graft versus host disease (GVHD) occurs in up to 40% of patients undergoing allogenic hematopoietic stem cell transplantation (HSCT). However, the optimal endoscopic approach is still unclear and the area of the GI tract with the highest diagnostic yield is still a topic of debate.
OBJECTIVE
We compared the diagnostic yield of different anatomic site biopsies in the diagnosis of GI GVHD and assessed the correlation of endoscopic findings with histopathology.
METHODS
All cases of biopsy proven GI GVHD were obtained from pathology database AUBMC between 1/1/2005 and 31/8/2017. We retrospectively analyzed the demographical, clinical and endoscopic data.
RESULTS
Nineteen patients were diagnosed with GI GVHD over 17.6 years. The most common presenting symptom was severe diarrhea (18 patients, 94.7%). Combining upper endoscopy and sigmoidoscopy with biopsies had the highest diagnostic yield of 90% in diagnosing GI GVHD compared to 63.6%, 78.6% and 77.8% for upper endoscopy, sigmoidoscopy and colonoscopy respectively. In macroscopically normal mucosa, the recto-sigmoid and duodenal biopsies had the highest diagnostic yield (75%). As for the macroscopically abnormal mucosa, the highest yield was for the recto-sigmoid biopsies (100%) in lower endoscopy and duodenal biopsies in the upper endoscopy (60%).
CONCLUSION
In a patient suspected to have GI GVHD, the best endoscopic approach is the combination of upper endoscopy and flexible sigmoidoscopy with biopsies of normal as well as abnormal mucosa. It should be emphasized that normal mucosa be biopsied especially in the duodenum and recto-sigmoid for a better diagnostic yield.

Identifiants

pubmed: 30206046
pii: S2452-3186(18)30036-9
doi: 10.1016/j.retram.2018.08.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-19

Informations de copyright

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Auteurs

Fady Daniel (F)

Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Lebanon.

Lara Hassoun (L)

Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Lebanon.

Mohammad Husni (M)

Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Lebanon.

Alaa Sharara (A)

Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Lebanon.

Assad Soweid (A)

Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Lebanon.

Kassem Barada (K)

Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Lebanon.

Basel Haffar (B)

Bone Marrow Transplantation Program, Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Lebanon.

Radwan Massoud (R)

Bone Marrow Transplantation Program, Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Lebanon.

Yasser Shaib (Y)

Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Lebanon.

Jana Al-Hashash (J)

Department of Internal Medicine, Division of Gastroenterology, American University of Beirut Medical Center, Lebanon.

Ali Bazarbachi (A)

Bone Marrow Transplantation Program, Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Lebanon.

Jean El Cheikh (J)

Bone Marrow Transplantation Program, Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Lebanon. Electronic address: je46@aub.edu.lb.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH